Heron Paul, McCloud Tayla, Arundel Catherine, Bailey Della, Ker Suzy, Li Jinshuo, Mishu Masuma, Osborn David, Parrott Steve, Peckham Emily, Stribling Alison, Gilbody Simon
Mental Health and Addiction Research Group, University of York, UK.
Division of Psychiatry, University College London, UK.
BJPsych Bull. 2019 Jun 4:6-11. doi: 10.1192/bjb.2019.39.
Aims and methodThe SCIMITAR+ trial was commissioned to evaluate the effectiveness of a bespoke smoking cessation intervention for people with severe mental ill health compared with usual services. It is difficult to define what constitutes usual care in smoking cessation services. We aimed to define what this was during the trial. Twenty-two National Health Service healthcare providers participated in a bespoke survey asking about usual care in their area. RESULTS: All sites offered smoking cessation support; however, service provider and service type varied substantially. In some cases services were not streamlined, meaning that people received smoking cessation counselling from one organisation and smoking cessation medication from another.Clinical implicationsTo better implement the National Institute for Health and Care Excellence guideline PH48, clearer referral pathways need to be implemented and communicated to patients, staff and carers. People with severe mental ill health need to be able to access services that combine nicotine replacement therapy and behavioural support in a streamlined manner.Declaration of interestNone.
目的与方法
“SCIMITAR+试验”旨在评估一种为严重精神疾病患者量身定制的戒烟干预措施相较于常规服务的有效性。在戒烟服务中，很难界定什么构成常规护理。我们旨在确定试验期间常规护理的内容。22家国民保健服务医疗服务提供者参与了一项定制调查，询问其所在地区的常规护理情况。
所有地点均提供戒烟支持；然而，服务提供者和服务类型差异很大。在某些情况下，服务流程不顺畅，这意味着人们从一个组织获得戒烟咨询，从另一个组织获得戒烟药物。
临床意义
为了更好地实施英国国家卫生与临床优化研究所（NICE）的PH48指南，需要实施更清晰的转诊途径，并向患者、工作人员和护理人员进行传达。患有严重精神疾病的人需要能够以简化的方式获得结合尼古丁替代疗法和行为支持的服务。
利益声明
无。
